Aaron G. Schmidt mainly investigates Antibody, Virology, Neutralizing antibody, Immunology and Severe acute respiratory syndrome coronavirus 2. His work in Antibody addresses subjects such as Immunity, which are connected to disciplines such as Immunogenicity, Vaccination and Viral load. His studies deal with areas such as Mutation, Cytotoxic T cell and Lineage as well as Virology.
His Neutralizing antibody research is multidisciplinary, relying on both Titer, Seroconversion and Isotype. His work on Humoral immunity, Antibody Profile and Serology is typically connected to Pandemic as part of general Immunology study, connecting several disciplines of science. In the field of Virus, his study on Viral replication overlaps with subjects such as Cypa.
The scientist’s investigation covers issues in Antibody, Virology, Nuclear physics, Epitope and Immune system. His Hemagglutinin and Serology study, which is part of a larger body of work in Antibody, is frequently linked to Severe acute respiratory syndrome coronavirus 2, bridging the gap between disciplines. His work focuses on many connections between Virology and other disciplines, such as Immunization, that overlap with his field of interest in Vector.
His studies in Epitope integrate themes in fields like Glycoprotein, Influenza vaccine, Monoclonal antibody and Antigenic variation. His study in Vaccination is interdisciplinary in nature, drawing from both Neutralizing antibody and Immunogenicity. Aaron G. Schmidt has researched Cell biology in several fields, including Interferon, Interferon-stimulated gene and Downregulation and upregulation.
Aaron G. Schmidt focuses on Antibody, Virology, Immune system, Severe acute respiratory syndrome coronavirus 2 and Immunology. His study in the fields of Serology, Epitope, Neutralization and Humoral immunity under the domain of Antibody overlaps with other disciplines such as Coronavirus. In general Virology, his work in Vaccination is often linked to Pandemic linking many areas of study.
His Vaccination study integrates concerns from other disciplines, such as Neutralizing antibody and Immunogenicity. His Immunology research is multidisciplinary, incorporating perspectives in Disease and Pneumonia. His Cell biology study incorporates themes from Proteases, Cell culture and Single-cell analysis.
Antibody, Immunology, Severe acute respiratory syndrome coronavirus 2, Immune system and Neutralizing antibody are his primary areas of study. Aaron G. Schmidt works mostly in the field of Antibody, limiting it down to topics relating to Vaccination and, in certain cases, Immunogenicity. His study looks at the relationship between Immunology and topics such as Pneumonia, which overlap with Viral replication, Respiratory failure, Pathogenesis and Rhesus macaque.
His work in Immune system covers topics such as Germinal center which are related to areas like Memory B cell, Somatic hypermutation, Mutation and Somatic cell. His research in Neutralizing antibody intersects with topics in Vector, Seroconversion, Immunization and Viral load. His Docking research focuses on Cell biology and how it connects with Cell culture.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
Carly G.K. Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian M. Mbano.
Cell (2020)
SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues
Carly Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian Mbano.
Social Science Research Network (2020)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Wilfredo F. Garcia-Beltran;Wilfredo F. Garcia-Beltran;Evan C. Lam;Kerri St. Denis;Adam D. Nitido.
Cell (2021)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
Jingyou Yu;Lisa H. Tostanoski;Lauren Peter;Noe B. Mercado.
Science (2020)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
Abishek Chandrashekar;Jinyan Liu;Amanda J. Martinot;Amanda J. Martinot;Katherine McMahan.
Science (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Noe B. Mercado;Roland Zahn;Frank Wegmann;Carolin Loos;Carolin Loos.
Nature (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
Thomas Mandel Clausen;Thomas Mandel Clausen;Thomas Mandel Clausen;Daniel R. Sandoval;Charlotte B. Spliid;Charlotte B. Spliid;Charlotte B. Spliid;Jessica Pihl;Jessica Pihl;Jessica Pihl.
Cell (2020)
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.
Anita S. Iyer;Forrest K. Jones;Ariana Nodoushani;Meagan Kelly.
Science immunology (2020)
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
Naoki Kaneko;Hsiao-Hsuan Kuo;Julie Boucau;Jocelyn R. Farmer.
Cell (2020)
COVID-19-neutralizing antibodies predict disease severity and survival.
Wilfredo F. Garcia-Beltran;Evan C. Lam;Michael G. Astudillo;Diane Yang.
Cell (2021)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Harvard University
MIT
Harvard Medical School
Harvard University
Harvard University
Boston University
Duke University
Duke University
Duke University
Polytechnic University of Turin
Johnson & Johnson (United States)
University of Minnesota
Sophia University
Leiden University
Lund University
Karolinska Institute
Tohoku University
Durham University
University of Edinburgh
Harvard University
University of California, San Diego
Ludwig-Maximilians-Universität München
University of Toronto
The University of Texas at Austin
The University of Texas at Austin